Results 21 to 30 of about 27,712 (197)

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation

open access: yesAdvances in Radiation Oncology, 2022
Purpose: Whole gland cryoablation is a guideline-approved definitive treatment for localized prostate cancer, and is being explored for partial gland ablation. However, there is limited data regarding management of cryoablation failures.
Jonathan W. Lischalk, MD   +9 more
doaj   +1 more source

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

open access: yesFrontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani   +3 more
doaj   +1 more source

Changing paradigm of radiation therapy for the treatment of pancreatic cancer

open access: yesPrecision Radiation Oncology, 2019
The evidence supporting the use of radiation therapy (RT) for pancreatic cancer (PC) treatment is highly variable, with studies both showing and failing to show that RT provides a survival benefit.
Beth K Neilsen, Chi Lin
doaj   +1 more source

The role of biological dose-escalation for pancreatic cancer

open access: yesClinical and Translational Radiation Oncology, 2019
The role of chemo-radiotherapy for treatment of locally advanced pancreatic cancer (LAPC) has been discussed for many years, and the absence of an overall survival benefit compared to gemcitabine chemotherapy alone in the recent LAP07 study seems to have
Anna M.E. Bruynzeel, Frank J. Lagerwaard
doaj   +1 more source

Radiation Oncology Residency Training in Latin America: A Call to Attention

open access: yesAdvances in Radiation Oncology, 2022
Purpose: Despite the call to increase the number of radiation oncologists in Latin America, the quality, similarity, and number of residency training programs are unknown.
Benjamin Li, MD, MBA   +11 more
doaj   +1 more source

Spectrum of Imaging Patterns of Lung Cancer following Radiation Therapy

open access: yesDiagnostics, 2023
Radiation therapy using conventional or newer high-precision dose techniques, including three-dimensional conformal radiotherapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, four-dimensional conformational radiotherapy ...
Taylor A. Strange   +6 more
doaj   +1 more source

Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study

open access: yesRadiology and Oncology, 2021
The aim of the study was to evaluate acute side effects after extremely hypofractionated intensity-modulated radiotherapy (IMRT) with stereotactic body radiation therapy (SBRT) for definitive treatment of prostate cancer patients.
Jorgo Kliton   +5 more
doaj   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

open access: yesMolecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy   +10 more
wiley   +1 more source

Stereotactic body radiation therapy for multiple lung cancers in a patient with six primary cancers: a case report

open access: yesJournal of Medical Case Reports
Background Surgery is the standard care for patients with early-stage lung cancer, and stereotactic body radiation therapy is an option for those who are medically inoperable or refuse surgery.
Naoko Ishida   +7 more
doaj   +1 more source

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

open access: yesAging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy